TAS2R63P and renal pelvis/ureter urothelial carcinoma: This indicated that assessments of pS6+ cells may serve as a potential prognostic marker for UTUC diagnosis, as was also demonstrated by the Kaplan-Meier analysis of relapse-free survival in patients with UTUC who had undergone focal treatment.